Abstract
The Src-family protein tyrosine kinases (SFKs) are known to play key roles in initiating signal transduction by the B-cell antigen receptor (BCR). In addition, numerous studies have shown that this family of molecules also contributes to signaling by BCR surrogates during B-lymphocyte lineage development and maturation. Paradoxically, ablation of SFKs not only results in obvious defects in B-cell development but also in the onset of autoimmunity. Thus SFKs, most notably Lyn, play both activating and inhibitory roles in B-cell function. Confounding analyses of SFK function in B cells is the varied coexpression of family members that mediate redundant as well as unique functions. In this review, we will focus mainly on the role of Lyn in mediating positive and negative roles in B-cell activation and how these affect immune signaling and disease progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adachi T, Flaswinkel H, Yakura H, Reth M and Tsubata T . (1998). J. Immunol., 160, 4662–4665.
Awasthi-Kalia M, Schnetkamp PP and Deans JP . (2001). Biochem. Biophys. Res. Commun., 287, 77–82.
Brdicka T, Pavlistova D, Leo A, Bruyns E, Korinek V, Angelisova P, Scherer J, Shevchenko A, Hilgert I, Cerny J, Drbal K, Kuramitsu Y, Kornacker B, Horejsi V and Schraven B . (2000). J. Exp. Med., 191, 1591–1604.
Buhl AM, Pleiman CM, Rickert RC and Cambier JC . (1997). J. Exp. Med., 186, 1897–1910.
Cahir McFarland ED, Hurley TR, Pingel JT, Sefton BM, Shaw A and Thomas ML . (1993). Proc. Natl. Acad. Sci. USA, 90, 1402–1406.
Cambier JC . (1995). Immunol. Today, 16, 110.
Cambier JC, Pleiman CM and Clark MR . (1994). Annu. Rev. Immunol., 12, 457–486.
Campbell KS, Bedzyk WD and Cambier JC . (1995). Mol. Immunol., 32, 1283–1294.
Chan VW, Lowell CA and DeFranco AL . (1998). Curr. Biol., 8, 545–553.
Chan VW, Meng F, Soriano P, DeFranco AL and Lowell CA . (1997). Immunity, 7, 69–81.
Clark MR, Campbell KS, Kazlauskas A, Johnson SA, Hertz M, Potter TA, Pleiman C and Cambier JC . (1992). Science, 258, 123–126.
Clark MR, Johnson SA and Cambier JC . (1994). EMBO J., 13, 1911–1919.
Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA and Goodnow CC . (1998). Immunity, 8, 497–508.
Cornall RJ, Goodnow CC and Cyster JG . (1999). Curr. Top. Microbiol. Immunol., 244, 57–68.
DeFranco AL, Chan VW and Lowell CA . (1998). Semin. Immunol., 10, 299–307.
Fong DC, Brauweiler A, Minskoff SA, Bruhns P, Tamir I, Mellman I, Daeron M and Cambier JC . (2000). J. Immunol., 165, 4453–4462.
Fuentes-Panana EM, Bannish G and Monroe JG . (2004). Immunol. Rev., 197, 26–40.
Fujimoto M, Bradney AP, Poe JC, Steeber DA and Tedder TF . (1999a). Immunity, 11, 191–200.
Fujimoto M, Fujimoto Y, Poe JC, Jansen PJ, Lowell CA, DeFranco AL and Tedder TF . (2000a). Immunity, 13, 47–57.
Fujimoto M, Poe JC, Hasegawa M and Tedder TF . (2000b). Immunol. Res., 22, 281–298.
Fujimoto M, Poe JC, Hasegawa M and Tedder TF . (2001). J. Biol. Chem., 276, 44820–44827.
Fujimoto M, Poe JC, Jansen PJ, Sato S and Tedder TF . (1999b). J. Immunol., 162, 7088–7094.
Gupta N and DeFranco AL . (2003). Mol. Cell. Biol., 14, 432–444.
Hasegawa M, Fujimoto M, Poe JC, Steeber DA, Lowell CA and Tedder TF . (2001). J. Immunol., 167, 2469–2478.
Hibbs ML, Harder KW, Armes J, Kountouri N, Quilici C, Casagranda F, Dunn AR and Tarlinton DM . (2002). J. Exp. Med., 196, 1593–1604.
Hong JJ, Yankee TM, Harrison ML and Geahlen RL . (2002). J. Biol. Chem., 277, 31703–31714.
Hsueh RC and Scheuermann RH . (2000). Adv. Immunol., 75, 283–316.
Janas ML, Hodgkin P, Hibbs M and Tarlinton D . (1999). J. Immunol., 163, 4192–4198.
Johnson SA, Pleiman CM, Pao L, Schneringer J, Hippen K and Cambier JC . (1995). J. Immunol., 155, 4596–4603.
Katagiri T, Ogimoto M, Hasegawa K, Arimura Y, Mitomo K, Okada M, Clark MR, Mizuno K and Yakura H . (1999). J. Immunol., 163, 1321–1326.
Kurosaki T . (1999). Annu. Rev. Immunol., 17, 555–592.
Lang P, Stolpa JC, Freiberg BA, Crawford F, Kappler J, Kupfer A and Cambier JC . (2001). Science, 291, 1537–1540.
Lankester AC, van Schijndel GM, Rood PM, Verhoeven AJ and van Lier RA . (1994). Eur. J. Immunol., 24, 2818–2825.
Lee KH, Dinner AR, Tu C, Campi G, Raychaudhuri S, Varma R, Sims TN, Burack WR, Wu H, Wang J, Kanagawa O, Markiewicz M, Allen PM, Dustin ML, Chakraborty AK and Shaw AS . (2003). Science, 302, 1218–1222.
Lee KH, Holdorf AD, Dustin ML, Chan AC, Allen PM and Shaw AS . (2002). Science, 295, 1539–1542.
Maeda A, Scharenberg AM, Tsukada S, Bolen JB, Kinet JP and Kurosaki T . (1999). Oncogene, 18, 2291–2297.
Meade J, Fernandez C and Turner M . (2002). Eur. J. Immunol., 32, 1029–1034.
Nada S, Okada M, MacAuley A, Cooper JA and Nakagawa H . (1991). Nature, 351, 69–72.
Nishizumi H, Horikawa K, Mlinaric-Rascan I and Yamamoto T . (1998). J. Exp. Med., 187, 1343–1348.
Okazaki T, Maeda A, Nishimura H, Kurosaki T and Honjo T . (2001). Proc. Natl. Acad. Sci. USA, 98, 13866–13871.
O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VL and Fearon DT . (1998). Immunity, 8, 635–645.
Otipoby KL, Draves KE and Clark EA . (2001). J. Biol. Chem., 276, 44315–44322.
Pani G, Kozlowski M, Cambier JC, Mills GB and Siminovitch KA . (1995). J. Exp. Med., 181, 2077–2084.
Pao LI and Cambier JC . (1997). J. Immunol., 158, 2663–2669.
Pao LI, Famiglietti SJ and Cambier JC . (1998). J. Immunol., 160, 3305–3314.
Pleiman CM, Abrams C, Gauen LT, Bedzyk W, Jongstra J, Shaw AS and Cambier JC . (1994). Proc. Natl. Acad. Sci. USA, 91, 4268–4272.
Pracht C, Gimborn K, Reth M and Huber M . (2002). Eur. J. Immunol., 32, 1614–1620.
Resh MD . (1993). Biochim. Biophys. Acta, 1155, 307–322.
Resh MD . (1994). Cell, 76, 411–413.
Resh MD . (1999). Biochim. Biophys. Acta, 1451, 1–16.
Roifman CM and Ke S . (1993). Biochem. Biophys. Res. Commun., 194, 222–225.
Saijo K, Schmedt C, Su IH, Karasuyama H, Lowell CA, Reth M, Adachi T, Patke A, Santana A and Tarakhovsky A . (2003). Nat. Immunol., 4, 274–279.
Sato S, Jansen PJ and Tedder TF . (1997). Proc. Natl. Acad. Sci. USA, 94, 13158–13162.
Sen G, Bikah G, Venkataraman C and Bondada S . (1999). Eur. J. Immunol., 29, 3319–3328.
Shrivastava P, Katagiri T, Ogimoto M, Mizuno K and Yakura H . (2004). Blood, 103, 1425–1432.
Smith KG, Tarlinton DM, Doody GM, Hibbs ML and Fearon DT . (1998). J. Exp. Med., 187, 807–811.
Sproul TW, Malapati S, Kim J and Pierce SK . (2000). J. Immunol., 165, 6020–6023.
Tatosyan AG and Mizenina OA . (2000). Biochemistry (Mosc.), 65, 49–58.
Tezuka T, Umemori H, Fusaki N, Yagi T, Takata M, Kurosaki T and Yamamoto T . (1996). J. Exp. Med., 183, 675–680.
Tuveson DA, Carter RH, Soltoff SP and Fearon DT . (1993). Science, 260, 986–989.
Wang J, Koizumi T and Watanabe T . (1996). J. Exp. Med., 184, 831–838.
Wechsler RJ and Monroe JG . (1995). J. Immunol., 154, 1919–1929.
Weng WK, Jarvis L and LeBien TW . (1994). J. Biol. Chem., 269, 32514–32521.
Whyburn LR, Halcomb KE, Contreras CM, Lowell CA, Witte ON and Satterthwaite AB . (2003). J. Immunol., 171, 1850–1858.
Wienands J, Larbolette O and Reth M . (1996). Proc. Natl. Acad. Sci. USA, 93, 7865–7870.
Xu W, Doshi A, Lei M, Eck MJ and Harrison SC . (1999). Mol. Cell, 3, 629–638.
Yamanashi Y, Kakiuchi T, Mizuguchi J, Yamamoto T and Toyoshima K . (1991). Science, 251, 192–194.
Yamanashi Y, Tamura T, Kanamori T, Yamane H, Nariuchi H, Yamamoto T and Baltimore D . (2000). Genes Dev., 14, 11–16.
Yanagi S, Sugawara H, Kurosaki M, Sabe H, Yamamura H and Kurosaki T . (1996). J. Biol. Chem., 271, 30487–30492.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gauld, S., Cambier, J. Src-family kinases in B-cell development and signaling. Oncogene 23, 8001–8006 (2004). https://doi.org/10.1038/sj.onc.1208075
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208075
Keywords
This article is cited by
-
Src Family Protein Kinase Controls the Fate of B Cells in Autoimmune Diseases
Inflammation (2021)
-
NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
Journal of Hematology & Oncology (2018)
-
Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products
Molecular Cancer (2018)
-
Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials
Nature Communications (2018)
-
Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation
Nature Communications (2017)